These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Autologous hematopoietic stem-cell transplantation for multiple myeloma. Harousseau JL; Moreau P N Engl J Med; 2009 Jun; 360(25):2645-54. PubMed ID: 19535803 [No Abstract] [Full Text] [Related]
25. [Current perspectives in the treatment of multiple myeloma - news and views]. Knop S Dtsch Med Wochenschr; 2012 Mar; 137(13):636-9. PubMed ID: 22434170 [No Abstract] [Full Text] [Related]
26. Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts. Vesole DH; Simic A; Lazarus HM Bone Marrow Transplant; 2001 Oct; 28(8):725-35. PubMed ID: 11781623 [TBL] [Abstract][Full Text] [Related]
27. The role of high-dose therapy with autologous stem cell support in the era of novel agents. Attal M; Harousseau JL Semin Hematol; 2009 Apr; 46(2):127-32. PubMed ID: 19389496 [TBL] [Abstract][Full Text] [Related]
28. Autologous stem cell transplantation in multiple myeloma: results of the European Group for Bone Marrow Transplantation. Björkstrand B; Ljungman P; Bird JM; Samson D; Brandt L; Alegre A; Auzanneau G; Bladé J; Brunet S; Carlson K Stem Cells; 1995 Aug; 13 Suppl 2():140-6. PubMed ID: 8520503 [TBL] [Abstract][Full Text] [Related]
30. Association of folate transporter SLC19A1 polymorphisms with the outcome of multiple myeloma after chemotherapy and tandem autologous transplantation. Maggini V; Buda G; Galimberti S; Conidi E; Giuliani N; Morabito F; Genestreti G; Iacopino P; Rizzoli V; Barale R; Petrini M; Rossi AM Leukemia; 2007 Jan; 21(1):176-8. PubMed ID: 17066090 [No Abstract] [Full Text] [Related]
31. The role of autologous stem cell transplantation in the management of multiple myeloma. Fermand JP; Brechignac S Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889 [TBL] [Abstract][Full Text] [Related]
34. High-dose chemotherapy in multiple myeloma. Goldschmidt H; Hegenbart U; Wallmeier M; Moos M; Haas R Leukemia; 1997 Dec; 11 Suppl 5():S27-31. PubMed ID: 9436935 [TBL] [Abstract][Full Text] [Related]
35. High-dose chemotherapy followed by autologous stem-cell transplantation in liver-transplanted multiple myeloma patients: a report of two cases. Peterlin P; Gastinne T; Moreau P; Harousseau JL; Le Gouill S Transplantation; 2009 Feb; 87(4):617-8. PubMed ID: 19307803 [No Abstract] [Full Text] [Related]
36. The evolution and impact of therapy in multiple myeloma. Laubach JP; Richardson PG; Anderson KC Med Oncol; 2010 Jun; 27 Suppl 1():S1-6. PubMed ID: 20169425 [TBL] [Abstract][Full Text] [Related]
37. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT. Ahmad I; Islam T; Chanan-Khan A; Hahn T; Wentling D; Becker JL; McCarthy PL; Alam AR Bone Marrow Transplant; 2002 Apr; 29(7):577-80. PubMed ID: 11979306 [TBL] [Abstract][Full Text] [Related]
38. Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma. Patriarca F; Sperotto A; Filì C; Zaja F; Prosdocimo S; Fanin R Haematologica; 2002 Jul; 87(7):779-81. PubMed ID: 12091134 [TBL] [Abstract][Full Text] [Related]